Interleukin-4 inhibits bone resorption through an effect on osteoclasts and proinflammatory cytokines in an ex vivo model of bone resorption in rheumatoid arthritis.

OBJECTIVE To assess local bone resorption in the context of rheumatoid synovitis and its modulation by interleukin-4 (IL-4). METHODS We developed an ex vivo model of bone resorption using juxtaarticular samples of bone obtained during joint surgery. We studied the histomorphometric parameters of bone resorption and the regulation of the production of IL-6, leukemia inhibitory factor (LIF), and the collagen cross-link pyridinoline, which is released during bone resorption in vivo. RESULTS This was a sensitive and dynamic model of bone resorption. The bone samples produced high levels of pyridinoline and as much cytokine as synovium pieces obtained from the same joint. IL-4 induced a 70% reduction of IL-6 and LIF production by bone pieces and reduced pyridinoline levels. Histomorphometric studies performed on bone samples indicated a 35% increase in the mean total bone area after 7 days of treatment with IL-4. More importantly, with IL-4, osteoclasts were not detectable in the bone sections. CONCLUSION The inhibitory effect of IL-4 on bone resorption extends our knowledge of its antiinflammatory properties and suggests that the inflammatory cytokine imbalance in rheumatoid synovium also contributes to defects in bone resorption in RA.

[1]  J. Banchereau,et al.  IL-4 inhibits growth factor-stimulated rheumatoid synoviocyte proliferation by blocking the early phases of the cell cycle. , 1993, Journal of immunology.

[2]  S. Wahl,et al.  Suppression of monocyte function and differential regulation of IL-1 and IL-1ra by IL-4 contribute to resolution of experimental arthritis. , 1993, Journal of immunology.

[3]  N. Gualde,et al.  Immunogenicity of HILDA/LIF either in a Soluble or in a Membrane Anchored Form expressed In Vivo by Recombinant Vaccinia Viruses , 1993, Scandinavian journal of immunology.

[4]  P. Delmas,et al.  Immunoassay of pyridinoline crosslink excretion in normal adults and in paget's disease , 1993, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[5]  M. Horowitz.  Cytokines and estrogen in bone: anti-osteoporotic effects. , 1993, Science.

[6]  T. Miyamoto,et al.  Interleukin-4 enhances in vitro mineralization in human osteoblast-like cells. , 1992, Biochemical and biophysical research communications.

[7]  H. Katai,et al.  Human fibroblasts synthesize elevated levels of extracellular matrix proteins in response to interleukin 4. , 1992, The Journal of clinical investigation.

[8]  P. Villiger,et al.  Leukemia inhibitory factor is expressed in cartilage and synovium and can contribute to the pathogenesis of arthritis. , 1992, The Journal of clinical investigation.

[9]  J. Banchereau,et al.  Inhibition of the production of proinflammatory cytokines and immunoglobulins by interleukin-4 in an ex vivo model of rheumatoid synovitis. , 1992, Arthritis and rheumatism.

[10]  H. Broxmeyer,et al.  Increased osteoclast development after estrogen loss: mediation by interleukin-6 , 1992 .

[11]  M. Gowen,et al.  Cytokines and bone. , 1992, British journal of rheumatology.

[12]  B. Klein,et al.  Human recombinant dimeric IL-6 binds to its receptor as detected by anti-IL-6 monoclonal antibodies. , 1991, Molecular immunology.

[13]  D. Lacey,et al.  Interleukin 4 inhibits murine osteoclast formation in vitro , 1991, Journal of cellular biochemistry.

[14]  C. Christiansen,et al.  Effect of menopause and hormone replacement therapy on the urinary excretion of pyridinium cross-links. , 1991, The Journal of clinical endocrinology and metabolism.

[15]  J. Banchereau,et al.  Low levels of interleukin-4 and high levels of transforming growth factor beta in rheumatoid synovitis. , 2010, Arthritis and rheumatism.

[16]  K. Watanabe,et al.  Interleukin-4 as a potent inhibitor of bone resorption. , 1990, Biochemical and biophysical research communications.

[17]  P. Miossec,et al.  Functional studies of soluble low-affinity interleukin-2 receptors in rheumatoid synovial fluid. , 1990, Arthritis and rheumatism.

[18]  F. Epstein,et al.  Rheumatoid arthritis. Pathophysiology and implications for therapy. , 1990, The New England journal of medicine.

[19]  R. Maki,et al.  Quantitative analysis of cytokine gene expression in rheumatoid arthritis. , 1990, Journal of immunology.

[20]  I. Reid,et al.  Leukemia Inhibitory Factor: A Novel Bone-Active Cytokine* , 1990 .

[21]  M. Ziff.  Rheumatoid arthritis--its present and future. , 1990, The Journal of rheumatology.

[22]  L. Avioli,et al.  Ovarian steroid treatment blocks a postmenopausal increase in blood monocyte interleukin 1 release. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[23]  P. Guerne,et al.  Synovium as a source of interleukin 6 in vitro. Contribution to local and systemic manifestations of arthritis. , 1989, The Journal of clinical investigation.

[24]  Y. Takebe,et al.  Isolation and characterization of multiple variants of recombinant human interleukin 4 expressed in mammalian cells. , 1988, The Journal of biological chemistry.

[25]  D. Heinegård,et al.  Detection of tumor necrosis factor alpha but not tumor necrosis factor beta in rheumatoid arthritis synovial fluid and serum. , 1988, Arthritis and rheumatism.

[26]  N. Miyasaka,et al.  Augmented interleukin-1 production and HLA-DR expression in the synovium of rheumatoid arthritis patients. Possible involvement in joint destruction. , 1988, Arthritis and rheumatism.

[27]  M. Liang,et al.  The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. , 1988, Arthritis and rheumatism.

[28]  B Henderson,et al.  Interleukin 1 induces leukocyte infiltration and cartilage proteoglycan degradation in the synovial joint. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[29]  C. Dinarello,et al.  Interleukin-1 lymphocyte chemotactic activity in rheumatoid arthritis synovial fluid. , 1986, Arthritis and rheumatism.

[30]  T. Bringman,et al.  Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factors , 1986, Nature.

[31]  R. Russell,et al.  An interleukin 1 like factor stimulates bone resorption in vitro , 1983, Nature.

[32]  M. Kurosaka,et al.  Immunoelectron microscopic study of the distribution of T cell subsets in rheumatoid synovium , 1983, The Journal of experimental medicine.

[33]  C. Dinarello,et al.  Isolation of an interleukin-1-like factor from human joint effusions. , 1983, Arthritis and rheumatism.

[34]  R. Winchester,et al.  Identification of Three Major Synovial Lining Cell Populations by Monoclonal Antibodies Directed to Ia Antigens and Antigens Associated with Monocytes/Macrophages and Fibroblasts , 1983, Scandinavian journal of immunology.